Pharmacy Grand Rounds - 6/14/2022- A Year in the Life: PGY-2 Edition

Tuesday, June 14, 2022, 12:00 AM - 2:00 PM, Dana Center

Please note that the time is 1:00-2:00 pm

June Pharmacy Grand Rounds

 Title:               “A Year in the Life: PGY-2 Edition”

 Schedule:         Tuesday, June 14th
                            Dana Center Auditorium (Please observe social distancing guidelines)
                            1:00-2:00pm

                            Click here for the zoom link: https://zoom.us/j/98328704386

                          
  Audience:        Jointly accredited for Pharmacists, Physicians, and Nurses
                            Other interested health care professionals welcomed

  Credits:           1 Contact Hour –knowledge based - 0.1 CEU will be awarded

  Presenter:       Paige Weaver, PharmD, PGY-2 Critical Care Resident
                           Julia Schwechheimer, PharmD, PGY-2 Oncology Resident
                            Rachel Perry, PharmD, PGY-2 Infectious Diseases Resident
                            Maine Medical Center

• Learning Objectives:
  After attending this program, participants will be able to:
  
  1. Evaluate the safety of dexmedetomidine when administered to non-intubated adult patients to treat alcohol withdrawal syndrome (AWS)
  2. Evaluate etoposide dosing practices in cancer patients with hepatic impairment and the incidence of etoposide-related toxicity, including additive hepatotoxicity, bone marrow suppression, and mucositis
  3. Describe the benefits of rapid diagnostic testing for patients with Gram negative bacteremia

Requirements for Receiving CE Credit:

•  Text attendance code provided during the talk to Cloud CME (207-808-7704)
•  Successful completion of post-presentation questions with 80% or better
•  Complete online program evaluation form
  
  

Statement of Disclosure:  Disclosure will be made on the day of the program regarding any interest or affiliation a speaker may have with a supporting organization

1. 1. Evaluate the safety of dexmedetomidine when administered to non-intubated adult patients to treat alcohol withdrawal syndrome (AWS)
2. 2. Evaluate etoposide dosing practices in cancer patients with hepatic impairment and the incidence of etoposide-related toxicity, including additive hepatotoxicity, bone marrow suppression, and mucositis
3. 3. Describe the benefits of rapid diagnostic testing for patients with Gram negative bacteremia

In support of improving patient care, MaineHealth is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  



DISCLOSURE:
All planners, faculty, and other in control of the content of this educational activity have no relevant financial relationships with ineligible entities (i.e., commercial organizations).

AMA PRA Category 1 Credits™ (1.00 hours), ACPE - Pharmacy (1.00 hours), ANCC - American Nurses Credentialing Center (1.00 hours), IPCE - Interprofessional Continuing Education (1.00 hours), Non-Physician Attendance (1.00 hours)

Date	Empty Column	Title
		No activities are currently published for this month.
No upcoming dates have been setup.